Simon Corman Chief Growth Officer: Welcome to FOMAT Medical
FOMAT Medical is proud to welcome Simon Corman Chief Growth Officer to our leadership team. With over 20 years of experience as a leader in clinical research, Simon brings a rare combination of strategic vision, operational depth, and entrepreneurial energy to the FOMAT Medical organization.
About Simon Corman Chief Growth Officer
Simon Corman Chief Growth Officer brings a career spanning some of the most demanding and innovative environments in clinical research. His strengths center on corporate and business development, with a proven ability to create strategic partnerships with CROs and Sponsors and form public private partnerships that support and accelerate clinical research initiatives.
Throughout his career, Simon has demonstrated a unique skill set — implementing new technology and diverse business models to drive organizational growth while maintaining the rigor and compliance that clinical research demands. He has contributed to the development of multiple innovative and agile organizations across the industry.
Senior Leadership Across Clinical Research
Simon has excelled in senior roles across the full spectrum of clinical research operations, including Central IRB, IRO/SMO/Site Network, and Full Service CRO environments. His breadth of experience gives him an unusually comprehensive perspective on how research organizations operate and grow.
Notably, Simon led one of the largest IRBs in North America, implementing industry cloud systems across financial and clinical operations. He has also led numerous quality management initiatives and guided organizations through AAHRP accreditation. His accumulated experience has allowed him to successfully guide the launch of the industry’s second largest network of centers and IROs.
Digital Transformation and Innovation
One of the most distinctive contributions Simon Corman Chief Growth Officer brings to FOMAT Medical is his deep involvement in digital transformation. He has participated in and led several initiatives reshaping how clinical trials are designed and executed, including eConsent, CTMS, eSource, EMR/EHR analytics, artificial intelligence applications, and Decentralized Trials.
This forward thinking approach aligns directly with FOMAT Medical’s mission to leverage technology and innovation in the delivery of high quality clinical research across the United States.
Why Simon Corman Chief Growth Officer at FOMAT Medical
FOMAT Medical operates as an embedded research organization conducting Phase I through Phase IV studies across multiple therapeutic areas. Simon’s business experience, creative vision, and deep industry knowledge — coupled with his inspirational and thoughtful leadership style — make him one of the best prepared professionals in the field.
To learn more about how FOMAT Medical conducts clinical research and how we partner with sponsors and CROs, visit our introduction to clinical trials or explore our patient active studies.
According to the Association of Clinical Research Professionals, leadership with cross functional expertise across IRB, CRO, and site network operations is among the most sought after profiles in the clinical research industry today.
It is an honor to welcome Simon Corman Chief Growth Officer to the FOMAT Medical Research team.